Clinical Trials Directory

Trials / Completed

CompletedNCT04257851

Is Theophylline More Effective Than Sumatriptan in the Treatment of Post-dural Puncture Headache

Is Theophylline More Effective Than Sumatriptan in the Treatment of Post-dural Puncture Headache: A Randomized Clinical Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Damanhour Teaching Hospital · Other Government
Sex
All
Age
21 Years – 50 Years
Healthy volunteers
Not accepted

Summary

Objectives: To compare the safety and efficacy of oral theophylline versus oral sumatriptan in the treatment of post-dural puncture headache (PDPH). Background: PDPH is the most frequent complication of procedures associated with dural puncture for spinal anesthesia or following accidental dural puncture during epidural anesthesia. Since invasive treatments have known complications, pharmacologic management may be preferable. Patients and Methods: This was a prospective, randomized, double-blind, phase four clinical trial; carried out on 60 patients presented with PDPH at our hospital. Patients were randomly allocated into two equal groups (30 patients each); group T, received oral theophylline, and group S, received oral sumatriptan.

Conditions

Interventions

TypeNameDescription
DRUGTheophylline Anhydrous Oral TabletTheophylline tablet (150 mg/12h)
DRUGSumatriptan Succinate Oral TabletSumatriptan tablet (25 mg/12h)

Timeline

Start date
2020-02-15
Primary completion
2021-05-15
Completion
2021-05-15
First posted
2020-02-06
Last updated
2021-06-03

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04257851. Inclusion in this directory is not an endorsement.